Tech Company Financing Transactions
Disco Pharmaceuticals Funding Round
AbbVie Biotech Ventures, M Ventures and Panakes Partners joined a $21.8 million Seed capital raise for Disco Pharmaceuticals. The round closed on 1/16/2024.
Transaction Overview
Company Name
Announced On
1/16/2024
Transaction Type
Venture Equity
Amount
$21,777,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D sector.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Gottfried-Hagen-Str. 60 -- 62
Cologne, 51105
Germany
Cologne, 51105
Germany
Phone
Undisclosed
Website
Email Address
Overview
At DISCO we are able to unlock the entire cancer cell surface at scale by identifying surface-bound proteins and uncovering protein communities. This approach thus permits unravelling comprehensive target information that neither standard proteomics, nor genome or transcriptome sequencing can provide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Roman Thomas
Chief Operating Officer
Johannes Heuckmann
Chief Scientific Officer
Stefan Ries
Chief Technical Officer
Emanuela Tschudy-Milani
Browse more venture capital transactions:
Prev: 1/16/2024: ZymoChem venture capital transaction
Next: 1/16/2024: CollateralEdge venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs